Aptatek Biosciences, Inc. Completes $4 Million Seed Funding Led By Ip Group, Inc. To Develop Advanced In-Home Monitoring Of Chronic Disease
Aptatek Biosciences, Inc. Completes $4 Million Seed Funding Led By Ip Group, Inc. To Develop Advanced In-Home Monitoring Of Chronic Disease
03/16/22, 11:00 AM
Location
Money raised
$4 million
Round Type
seed
Aptatek BioSciences, Inc., a developer of in-home health monitoring solutions for patients with chronic disease, announced the completion of a $4 million seed funding round led by hard science investment firm IP Group, Inc., Canterbury Scientific Limited, a leading global OEM developer and supplier of In Vitro Diagnostic (IVD) test consumables, and the National PKU Alliance (NPKUA) also participated in the round.